Kode Mata Kuliah | BT6142 / 3 SKS |
---|
Penyelenggara | 211 - Bioteknologi / SITH |
---|
Kategori | Kuliah |
---|
| Bahasa Indonesia | English |
---|
Nama Mata Kuliah | Vaksin dan Diagnostik | Vaccines and Diagnostics |
---|
Bahan Kajian | - Vaksin : Antigen, adjuvant, Jalur vaksinasi
- Reverse Vaccinology
- Diagnostik berbasis imunologi
- Diagnostik berbasis molekular
| - Vaccine: Antigen, adjuvant, Vaccination pathway
- Reverse Vaccinology
- Immunological based diagnostics
- Molecular-based diagnostics
|
---|
Capaian Pembelajaran Mata Kuliah (CPMK) | - Mampu mengaplikasi pengetahuan tentang infeksi dan imunologi untuk pengembangan kit diagnostik berbasis molekuler dan pengembangan kit diagnostik berbasis imunologi.
- Mampu merencanakan dan merancang pengembangan vaksin dan diagnostik kit berdasarkan pada pendekatan bioteknologi
- Mahasiswa dapat mempresentasikan secara tertulis dan oral hasil pembahasan terkait studi kasus dan rangkuman artikel yang sudah dipelajarinya terkait vaksin dan diagnostik
| - Able to apply knowledge of infection and immunology for the development of molecular-based diagnostic kits and the development of immunological-based diagnostic kits.
- Able to plan and design the development of vaccines and diagnostic kits based on a biotechnology approach.
- Students are able to present in writing and orally the results of discussions related to case studies and summaries of articles that have been studied related to vaccines and diagnostics.
|
---|
Metode Pembelajaran | Proses belajar dalam kelas, Penugasan terstruktur, Kegiatan mandiri | An in-class learning process, Structured assignments, Independent activities |
---|
Modalitas Pembelajaran | Moda penyerapan: Visual, Auditorial
Moda Pelaksanaan: Sinkronous, Asinkronous | Modes of absorption: Visual, Auditorial
Modes of Execution: Synchronous, Asynchronous |
---|
Jenis Nilai | ABCDE |
---|
Metode Penilaian | UTS 35%; UAS 35%; Presentasi 20%; Tugas dan lain-lain 10% | Midterm Exam 35%; Final Exam 35%; Presentation 20%; Assignments and others 10% |
---|
Catatan Tambahan | | |
---|